Tremendous disparities are known to exist in cardiovascular disease and its related outcomes. Much of this can be traced to poorly controlled hypertension and its attendant, pressure-related consequences, especially target-organ cardiac damage. The latter, which occurs prematurely and disproportionately in African- Americans, reduces both quality and quantity of life. The risk of target-organ cardiac damage is particularly high among inner-city African-Americans with hypertension, particularly those who utilize the emergency department for chronic blood pressure management. Like cardiovascular disease, vitamin D deficiency disproportionately affects African-Americans. Vitamin D is thought to be an important modifier of cardiovascular disparities through its direct (and, via parathyroid hormone, indirect) myocardial (hypertrophy, fibrosis) and vascular (increased resistance, loss of compliance) effects. Vitamin D repletion in those who are deficient has been postulated as mechanism to reduce the cardiovascular disease burden experienced by African- Americans, especially if initiated early before irreversible damage has occurred, but this has yet to be tested in a prospective clinical trial. Accordingly, this proposal was designed to investigate the relationship between vitamin D and subclinical target-organ cardiac damage (as identified on cardiac magnetic resonance imaging) in a cohort of African-American, vitamin D deficient hypertensive patients without prior history of heart disease. Specifically, we seek to ascertain the effect of adjunct vitamin D therapy on left ventricular hypertrophy (primary aim), myocardial fibrosis and central vascular function (secondary aims) at one-year using a placebo controlled, randomized design. Antihypertensive treatment in both study arms will be standardized and our focus will be recruitment of patients who present to our safety-net institution with poorly controlled blood pressure - a high-risk, high-reward subset who would stand to benefit tremendously from identification of an inexpensive intervention, which could effectively reduce the adverse impact of hypertension.

Public Health Relevance

African-Americans die younger and more often from hypertension and hypertensive heart disease than other races. Regression of left ventricular hypertrophy, a cardinal manifestation of elevated blood pressure, which disproportionately affects African-Americans, can reduce adverse events and, accordingly, has become a focal point of secondary prevention. Vitamin D deficiency may be an important contributor to racial differences in hypertensive heart disease but whether adjunct vitamin D therapy provides benefit is unknown.

National Institute of Health (NIH)
National Institute on Minority Health and Health Disparities (NIMHD)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZMD1-MLS (01))
Program Officer
Rajapakse, Nishadi
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Wayne State University
Emergency Medicine
Schools of Medicine
United States
Zip Code
Li, Xiangrui; Zhu, Dongxiao; Levy, Phillip (2018) Leveraging auxiliary measures: a deep multi-task neural network for predictive modeling in clinical research. BMC Med Inform Decis Mak 18:126
Fermann, Gregory J; Levy, Phillip D; Pang, Peter et al. (2017) Design and Rationale of a Randomized Trial of a Care Transition Strategy in Patients With Acute Heart Failure Discharged From the Emergency Department: GUIDED-HF (Get With the Guidelines in Emergency Department Patients With Heart Failure). Circ Heart Fail 10:
Barrett, Tyler W; Rising, Kristin L; Bellolio, M Fernanda et al. (2016) The 2016 Academic Emergency Medicine Consensus Conference, ""Shared Decision Making in the Emergency Department: Development of a Policy-relevant Patient-centered Research Agenda"" Diagnostic Testing Breakout Session Report. Acad Emerg Med 23:1354-1361
Ayaz, Syed Imran; Sharkey, Craig M; Kwiatkowski, Gregory M et al. (2016) Intravenous enalaprilat for treatment of acute hypertensive heart failure in the emergency department. Int J Emerg Med 9:28
Miller, Joseph B; Kinni, Harish; Amer, Ahmed et al. (2016) Therapies to Reduce Blood Pressure Acutely. Curr Hypertens Rep 18:43
Brody, Aaron; Janke, Alex; Sharma, Vineet et al. (2016) Public Health, Hypertension, and the Emergency Department. Curr Hypertens Rep 18:50
Goldberg, Elizabeth M; Levy, Phillip D (2016) New Approaches to Evaluating and Monitoring Blood Pressure. Curr Hypertens Rep 18:49
Goldberg, Elizabeth M; Levy, Phillip D; McNaughton, Candace D (2016) When More Isn't Better: Visits for Hypertension: September 2016 Annals of Emergency Medicine Journal Club. Ann Emerg Med 68:385-6
McNaughton, Candace D; Self, Wesley H; Zhu, Yuwei et al. (2015) Incidence of Hypertension-Related Emergency Department Visits in the United States, 2006 to 2012. Am J Cardiol 116:1717-23
Collins, Sean; Storrow, Alan B; Albert, Nancy M et al. (2015) Early management of patients with acute heart failure: state of the art and future directions. A consensus document from the society for academic emergency medicine/heart failure society of America acute heart failure working group. J Card Fail 21:27-43

Showing the most recent 10 out of 19 publications